Kantonsspital St.Gallen
login

Corrigendum to: Impact of the M184V/I Mutation on the Efficacy of Abacavir/Lamivudine/Dolutegravir Therapy in HIV Treatment-Experienced Patients

Flaminia Olearo, Huyen Nguyen, Fabrice Bonnet, Sabine Yerly, Gilles Wandeler, Marcel Stoeckle, Matthias Cavassini, Alexandra Scherrer, Dominique Costagliola, Patrick Schmid, Huldrych F Günthard, Enos Bernasconi, Jürg Boeni, Antonella D'arminio Monforte, Maurizio Zazzi, Barbara Rossetti, Didier Neau, Pantxika Bellecave, Bart Rijnders, Peter Reiss, Ferdinand Wit, Roger Kouyos & Alexandra Calmy

abstract [This corrects the article DOI: 10.1093/ofid/ofz330.][This corrects the article DOI: 10.1093/ofid/ofz330.].
   
citation Olearo F, Nguyen H, Bonnet F, Yerly S, Wandeler G, Stoeckle M, Cavassini M, Scherrer A, Costagliola D, Schmid P, Günthard H F, Bernasconi E, Boeni J, D'arminio Monforte A, Zazzi M, Rossetti B, Neau D, Bellecave P, Rijnders B, Reiss P, Wit F, Kouyos R, Calmy A. Corrigendum to: Impact of the M184V/I Mutation on the Efficacy of Abacavir/Lamivudine/Dolutegravir Therapy in HIV Treatment-Experienced Patients. Open Forum Infect Dis 2019; 6:ofz500.
   
type journal paper/review (English)
date of publishing 08-12-2019
journal title Open Forum Infect Dis (6/12)
ISSN print 2328-8957
pages ofz500
PubMed 31832485
DOI 10.1093/ofid/ofz500